Cargando…

Osteosclerotic change as a therapeutic response to gefitinib in symptomatic non-small cell lung cancer bone metastasis

BACKGROUND: Despite improvement in the overall survival of patients with non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutation, the effects of EGFR tyrosine kinase inhibitor (EGFR-TKI) treatment on bone metastasis remain unclear. This study investigated radiol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyagi, Michihito, Katagiri, Hirohisa, Murata, Hideki, Wasa, Junji, Takahashi, Toshiaki, Murakami, Haruyasu, Harada, Hideyuki, Mori, Keita, Takahashi, Mitsuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9801654/ https://www.ncbi.nlm.nih.gov/pubmed/36581856 http://dx.doi.org/10.1186/s12890-022-02226-1

Ejemplares similares

Direct femoral head approach without surgical dislocation for femoral head chondroblastoma: a report of two cases
por: Katagiri, Hirohisa, et al.
Publicado: (2022)

Fracture after radiation therapy for femoral metastasis: incidence, timing and clinical features
por: Shimoyama, Tetsuo, et al.
Publicado: (2017)

Osteosclerotic Prostatic Metastasis
por: Chedgy, Edmund C.P., et al.
Publicado: (2010)

Atypical Neurofibroma and Osteosclerotic Metastasis
por: Varyani, Neeraj, et al.
Publicado: (2012)

Posterior reversible encephalopathy syndrome (PRES) induced by pazopanib, a multi-targeting tyrosine kinase inhibitor, in a patient with soft-tissue sarcoma: case report and review of the literature
por: Deguchi, Shoichi, et al.
Publicado: (2017)

New prognostic factors and scoring system for patients with skeletal metastasis
por: Katagiri, Hirohisa, et al.
Publicado: (2014)

The Skull in Osteosclerotic Anæmia
por: Greig, David M.
Publicado: (1929)

Maxillomandibular giant osteosclerotic lesions
por: LEDESMA-MONTES, Constantino, et al.
Publicado: (2018)

Osteosclerotic & osteolytic lesions in multiple myeloma
por: Ram, Rapur, et al.
Publicado: (2014)

Focus on Osteosclerotic Progression in Primary Myelofibrosis
por: Spampinato, Mariarita, et al.
Publicado: (2021)

Reirradiation of spinal metastases with intensity-modulated radiation therapy: an analysis of 23 patients
por: Kawashiro, Shohei, et al.
Publicado: (2016)

Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study
por: Mitsuya, Koichi, et al.
Publicado: (2019)

Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Akamatsu, Hiroaki, et al.
Publicado: (2014)

Primary intraosseous meningioma: an osteosclerotic bone tumour mimicking malignancy
por: Vlychou, M., et al.
Publicado: (2016)

Skeletal Metastasis of Unknown Primary Origin at the Initial Visit: A Retrospective Analysis of 286 Cases
por: Takagi, Tatsuya, et al.
Publicado: (2015)

The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models
por: Martín-Fernández, Marta, et al.
Publicado: (2017)

Efficacy of prophylactic cranial irradiation in patients with limited-disease small-cell lung cancer who were confirmed to have no brain metastasis via magnetic resonance imaging after initial chemoradiotherapy
por: Mamesaya, Nobuaki, et al.
Publicado: (2018)

Clinical impact of post-progression survival on overall survival in patients with limited-stage disease small cell lung cancer after first-line chemoradiotherapy
por: Kasahara, Norimitsu, et al.
Publicado: (2015)

Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer
por: Imai, Hisao, et al.
Publicado: (2015)

Proposing synchronous oligometastatic non–small‐cell lung cancer based on progression after first‐line systemic therapy
por: Miyawaki, Taichi, et al.
Publicado: (2020)

Utility of osteosclerotic lesion biopsy in diagnosis of POEMS syndrome: A case report
por: Hara, Daisuke, et al.
Publicado: (2017)

Osteosclerotic Multiple Myeloma without POEMS Syndrome – A Rare Case Report
por: Divakar, M, et al.
Publicado: (2022)

Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome with Purely Osteolytic, Not Osteosclerotic, Lesions Mimicking a Malignant Tumor
por: Kinoshita, Hideyuki, et al.
Publicado: (2020)

Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study
por: Miyawaki, Taichi, et al.
Publicado: (2021)

Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC
por: Miyawaki, Taichi, et al.
Publicado: (2020)

Predicting the efficacy of first‐line immunotherapy by combining cancer cachexia and tumor burden in advanced non‐small cell lung cancer
por: Miyawaki, Taichi, et al.
Publicado: (2022)

Clinical impact of tumour burden on the efficacy of PD‐1/PD‐L1 inhibitors plus chemotherapy in non‐small‐cell lung cancer
por: Miyawaki, Taichi, et al.
Publicado: (2022)

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer
por: Yokouchi, Hiroshi, et al.
Publicado: (2007)

Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer
por: Takeuchi, Shinji, et al.
Publicado: (2020)

Impact of Interstitial Lung Disease Classification on the Development of Acute Exacerbation of Interstitial Lung Disease and Prognosis in Patients with Stage III Non-Small-Cell Lung Cancer and Interstitial Lung Disease Treated With Chemoradiotherapy
por: Kobayashi, Haruki, et al.
Publicado: (2018)

Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities
por: Kobayashi, Haruki, et al.
Publicado: (2021)

Comparison of platinum combination re-challenge therapy and docetaxel monotherapy in non-small cell lung cancer patients previously treated with platinum-based chemoradiotherapy
por: Imai, Hisao, et al.
Publicado: (2015)

A Rare Case of Aggressive Systemic Mastocytosis With Skeletal Osteosclerotic Lesions on Presentation: A Diagnostic Conundrum
por: Ghorpade, Rina, et al.
Publicado: (2022)

Altered sulfation status of FAM20C-dependent chondroitin sulfate is associated with osteosclerotic bone dysplasia
por: Koike, Toshiyasu, et al.
Publicado: (2022)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutation
por: Kawamura, Takahisa, et al.
Publicado: (2019)

Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients
por: Takahashi, Toshiaki, et al.
Publicado: (2010)

Peroxisome proliferator-activated receptor γ agonist efatutazone impairs transforming growth factor β2-induced motility of epidermal growth factor receptor tyrosine kinase inhibitor-resistant lung cancer cells
por: Serizawa, Masakuni, et al.
Publicado: (2014)

(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy
por: Uchida, Kenzo, et al.
Publicado: (2013)

Osteosclerotic and osteolytic manifestations of hyperparathyroidism in a case of Tc99m SestaMIBI positive parathyroid adenoma
por: Das, Kalpa Jyoti, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nfk4bm2in6hnehpq1mdqlp8n7e